Novo Nordisk (NVO) announced today that its blockbuster drug Ozempic was approved by the Food and Drug Administration (FDA) as the first GLP-1 treatment for chronic kidney disease among people with type 2 diabetes.Read more…Read More
Category Archives: Approved
Ozempic liver function You don’t have permission to access “http://www.medpagetoday.com/nephrology/diabetes/113985” on this server. Reference #18.351dc917.1738110839.6941054 https://errors.edgesuite.net/18.351dc917.1738110839.6941054 Read More